SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-18-102191
Filing Date
2018-03-29
Accepted
2018-03-29 17:13:56
Documents
1
Group Members
TAKEDA A/S (DENMARK)TAKEDA EUROPE HOLDINGS B.V. (NETHERLANDS)TAKEDA PHARMA A/S (DENMARK)TAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICALS INTERNATIONAL AGTAKEDA PHARMACEUTICALS U.S.A., INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d543329dsc13g.htm SC 13G 110576
  Complete submission text file 0001193125-18-102191.txt   112368
Mailing Address 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 40 LANDSDOWNE STREET CAMBRIDGE MA 02139 6176797000
MILLENNIUM PHARMACEUTICALS INC (Filed by) CIK: 0001002637 (see all company filings)

IRS No.: 043177038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-89732 | Film No.: 18723898
SIC: 2834 Pharmaceutical Preparations